10.50 - 11.12
3.81 - 12.83
1.80M / 1.61M (Avg.)
158.14 | 0.07
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
42.00%
G&A growth while CGAU reduces overhead. John Neff would investigate operational differences.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
184.58%
Operating expenses growth above 1.5x CGAU's 117.43%. Michael Burry would check for inefficiency.
184.58%
Total costs growth 1.25-1.5x CGAU's 136.47%. Martin Whitman would scrutinize control.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-184.58%
EBITDA decline while CGAU shows 526.47% growth. Joel Greenblatt would examine position.
No Data
No Data available this quarter, please select a different quarter.
-184.58%
Operating income decline while CGAU shows 4088.40% growth. Joel Greenblatt would examine position.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-1977.81%
Pre-tax income decline while CGAU shows 4313.33% growth. Joel Greenblatt would examine position.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-1977.81%
Net income decline while CGAU shows 6082.76% growth. Joel Greenblatt would examine position.
No Data
No Data available this quarter, please select a different quarter.
-2062.16%
EPS decline while CGAU shows 6100.00% growth. Joel Greenblatt would examine position.
-1927.03%
Diluted EPS decline while CGAU shows 6100.00% growth. Joel Greenblatt would examine position.
-0.97%
Share count reduction while CGAU shows 0.00% change. Joel Greenblatt would examine strategy.
-0.97%
Diluted share reduction while CGAU shows 0.01% change. Joel Greenblatt would examine strategy.